We are live on
!
Find out more
Tempest Therapeutics
TPST
TPST
29 hedge funds and large institutions have $85.1M invested in Tempest Therapeutics in 2013 Q2 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+29
Holders Change %
–
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
29
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SO
26
STRS Ohio
Columbus,
Ohio
| $58K | +$37.6K | +1 | New |
|
|
BA
27
BlackRock Advisors
Wilmington,
Delaware
| $55K | +$37.6K | +1 | New |
|
|
NFA
28
Nationwide Fund Advisors
Columbus,
Ohio
| $39K | +$37.6K | +1 | New |
|
|
U
29
UBS
Zurich,
Switzerland
| $33K | +$37.6K | +1 | New |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $13K | – | – | – |
|
31
AllianceBernstein
Nashville,
Tennessee
| $10K | – | – | – |
|
32
Ameriprise
Minneapolis,
Minnesota
| $8K | – | – | – |
|
33
Barclays
London,
United Kingdom
| $6K | – | – | – |
|
TPST Hedge Fund Activity: Q2 2013 in Review
29 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q2 2013, worth a combined $85.1M.
Buyers outnumbered sellers: 29 funds opened new TPST positions and 0 closed out — a net gain of 29 holders — while 0 added to existing stakes and 0 trimmed.
- 29 institutional investors held Tempest Therapeutics (TPST) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $85.1M of Tempest Therapeutics stock for Q2 2013.
- 29 funds opened new Tempest Therapeutics positions in Q2 2013 and 0 closed out, a net change of +29 holders.
Based on aggregated 13F filings for Q2 2013.